I am mostly a daytrader engaging in both long and short bets intraday and occasionally over the short to medium term. My focus is mostly on tech stocks and more recently the shipping and offshore drilling industry. I am located in Germany and have worked quite some time as an auditor for PricewaterhouseCoopers before becoming a daytrader more than 15 years ago. During this time I managed to successfully maneuver the burst of the dotcom bubble and the aftermath of the world trade center attacks as well as the subprime crisis. My return on invested capital has been mostly good and at times reaches up to several 100% annually so I will most likely be around for some more years.
Whether you are a large or small firm, GeoInvesting will cater to your needs and create a sound process for corporate diligence. Our specialty is Portfolio Protection – in fact, every aspect of what we do boils down to various ways that your M&A process or investment portfolio can be safeguarded against red flags.
To accomplish this we choose to work closely with you so you can be kept abreast of the progress of our due diligence from start to finish, making sure that we cultivate a relationship of trust between our team and yours.
Who Can We Help Specifically?
We actually do not limit ourselves to any specific group? We have worked at great lengths with:
>High Net Worth Investors
>Private & Public M&A
>Other Due Diligence Firms
There is really no one that we can’t work with since we’ve covered just about every facet of the due diligence process, whether it be on-the-ground or “through the files.” We can even tailor our services to your specific requirements.
We have a retail solution for everyone – the long investor, the short investor, the pump and dump investor and the every day trader that is interested in the micro cap arena. We’ve shown that we can overcome the challenges posed by any market environment, quickly seizing investment and trading opportunities as they arise. Because of this, our Premium members have been able to enjoy above-average returns on our ideas. Our solutions enable us to cater to what matters to you the most.
Do you want access to reports that can convey the proper valuation of equities, reports that can immediately convince the market that these valuations are warranted? Do you want information arbitrage that allows you to be among the first to take action based on the intel? Do you need daily ideas, some of which have proven to be some of the most rewarding calls to action that the GeoTeam has offered? Would you like to follow our GeoBargains and select trades? Or do you just need to be part of an exclusive twitter following that receives alerts before the rest of the market?
If you have answered yes to any of the questions above, then don’t wait any longer. Join our Network and see why our following continues to grow on a daily basis. The faster you join, the more likely you will be among the first to harness the power of our offering.
Sign up today and start to get:
>Daily Trading Ideas
See GeoInvesting Prime on Seeking Alpha Marketplace
Craig Keolanui is a biotechnology investor and bioengineering major from UCSD. Presently a small business consultant, freelance writer and start-up business guru, Keolanui offers small business writing services and support through the site, mybizwriters.com. Through his website, Keolanui helps many business owners save money and time, while ensuring that marketing and buzz about the business is maintained at a reasonable cost. He has been a biotech researcher and investor for over 15 years and presently has long positions in high yield dividend stocks as well as high risk biotech equities.
Ivy League grad, summa cum laude, 4.0 in Economics, Columbia J.D., 20+ years experience identifying early trends and themes b4 the Wall St herd. In search of undervalued, underfollowed, explosive growth opportunities, principally in, but not limited to, the biotech sector.
Tomas Leszczynski is a founder of a Registered Investment Advisory firm Santoren Inc. He makes all investment decisions for Santoren clients.
CEO, Founder, Santoren Inc.
August 2006 – Present (6 years 8 months)
Santoren is a Registered Investment Advisory firm providing investment services to private clients. Tomas Leszczynski is responsible for all trading decisions and operations at the company. The services include portfolio management, estate planning, and business development services. Tomas Leszczynski holds series 7 and series 66 registrations.
CEO, Founder, MugToGo Inc.
January 1999 – August 2011 (12 years 8 months)
First disposable paper mug on the market for coffee industry. Directed a development of mass volume production lines; managed a team of 20+, culminating in a market introduction at Barnes & Noble.
Co-founder, Managing Partner, Angen Advisors LLC.
2008 – 2009 (1 year)
Angen provides Financial Senior Executive talent and services to startups, entrepreneurial firms and businesses.
Financial Advisor, McGinn Smith & Co. Inc.
2005 – 2006 (1 year)
Financial Advisor at the Investment Bank on Wall Street.
Financial Advisor, UBS
2003 – 2005 (2 years)
Managed accounts of high net worth investors at a private client group located at the headquarters of UBS in New York.
CEO, Founder, Creative Director, Abacus Graphics Ltd.
1984 – 1998 (14 years)
Founded one of the first computer graphics companies in New York. Directed all operations, including the management of 12+ crew. Developed large client accounts, including: American Express, Chase, Seagrams, Random House, Fodor's, Pfizer.
I am an independent trader looking for undervalued stocks with high growth prospects.
Of particular interest to me are:
Small biopharmas with nice product pipelines.
Legitimate Chinese small caps.
Stable high dividend stocks.
This year, I have made good gains on CALI and ADNC by getting in early.
Editor for The Biotech Forum & The Insiders Forum; two of the most subscribed to services available via SeekingAlpha's MarketPlace. Long time Real Money Pro contributor. Biotech investor for a quarter century and frequent speaker on the topic at investment conferences like the MoneyShow and in interviews. For FREE weekly investment reports on small, attractive biotech stocks just register at biotechfreereports.com. To get my articles and instablogs as soon as they are published, please hit my profile and become a real-time follower.
Kapitall is the online finance platform for the next generation, where investing is as easy as drag, drop and trade. With an intuitive and playful user experience, Kapitall offers tools that make it easy to build virtual and real brokerage portfolios, share ideas and research stocks and funds.
Graham Summers is Chief Market Strategist of Phoenix Capital Research, a global investment strategy firm located in Washington, DC. He is a Fuqua Business School MBA graduate, and has over a decade of experience in investment strategy, financial research, and private wealth management.
An acclaimed communicator and strategist, Graham’s cutting edge business and research insights have been featured in several media outlets around the world including: CNN Money, Fox Business, Rolling Stone Magazine, Crain’s New York Business, the New York Post, MoneyTalk Radio, and The Huffington Post among many others.
Michael Ashton has been a recognized leader in developing the U.S. inflation derivatives market. He traded the first interbank U.S. CPI swaps in 2003 and, as a dealer, was a primary liquidity-provider in that market for two large banks. He represented about one-third of interbank swaps volume during his tenures at those firms. He invented and was the sole market-maker for the CME CPI Futures contract. He has written and spoken extensively about the use of inflation-indexed products for hedging real exposures, and has written more broadly in a commentary format about the rates markets and macroeconomy. Mr. Ashton is currently the managing principal at Enduring Investments LLC. His comments on this site and others are not posted in that role, and no opinions of his should be construed to be recommendations of or to reflect the views of his employer. He recently published "What's Wrong With Money? The Biggest Bubble of All."
Jon Slotnick is a stock analyst and trader who currently provides stock analysis and alerts to several financial websites. He has also worked as a freelance copywriter for TD Ameritrade's active trader initiatives, and written a series of financial literacy DVDs for New York Times bestselling author Julie Stav. He has a Masters Degree in Journalism from UC Berkeley.
M.E. Garza is one of the founders of the biotech and healthcare sector news portal BioMedReports.com. He believes in getting the news from credible sources on the street and often reaches out to CEOs and newsmakers directly for interviews and discussions about their companies. Since he began publishing in 2008, Garza has built a reputation as a writer and reporter who can move markets. His track record for accurately reporting rumors and alerting readers about developments in the biotech/healthcare sector is unmatched during that time.
Marco is a trader of stocks, options, currencies, and futures. He has been fascinated with the financial markets ever since he bought his first stock at 11 years old. Marco entered the business world at the age of 13, with the creation of an extremely successful retail website (GoldenAgeCheese.com), that of which he still has a major role in today. Marco writes about stocks and options whenever he gets the chance. He's dedicated to educate his readers to the best of his ability about the financial markets, particularly about buying/selling options and different strategies. 2008 was one of the most profitable years trading stocks and options for Marco. He trades based on technicals and fundamentals, so you may find many of his posts valuable.